BioPharmaceuticals
Home / Our therapy areas / BioPharmaceuticals
Our Ambition for Change
Every day, around the world billions of people are trying to balance living their lives with the challenges of living with chronic diseases. In India, one in four people is likely to die of a chronic disease. These diseases, which include cardiovascular, renal, metabolic, respiratory, and immunological conditions, are leading causes of death across the globe.
Our ambition is to stop the progress of these often degenerative, debilitating and life-threatening conditions, and to positively impact the lives of patients facing these challenges.
Innovating for Impact across Chronic Diseases
The way we follow science is already starting to impact the trajectory of care across chronic diseases. To continue to create an impact on disease, we are dedicated to enhancing disease understanding, broadening our therapeutic platforms, better predicting clinical outcomes, and pioneering new approaches in the clinic.
The aim is to deliver innovative healthcare solutions and equitable access to treatment.
Our Disease Areas
BioPharmaceuticals is responsible for our key therapy areas of Cardiovascular, Renal & Metabolism and Respiratory & Immunology
Collaborating for Impact
We understand that despite the innovation in our science, we cannot accomplish everything independently. Therefore, we aim to forge mutually beneficial partnerships based on trust and transparency, spanning from drug discovery to commercial endeavors.
The goal is to stimulate innovation and accelerate the delivery of new medicines that target unmet medical needs.
Our Medicines
Our drug discovery and development are guided by our ‘5R Framework’. This approach prioritizes quality over quantity and has helped transform the culture of R&D to unlock the potential of our life-changing medicines for patients
We are also integrating science with real-world practice to evolve treatment landscapes and improve care for patients.
Latest Updates
Approval ID: IN-15381 | Approved Date: 13/11/2024 | Expiration Date: 13/11/2026